Dianthus Therapeutics Inc. 宣布,公司拟将此次融资的净收益主要用于支持其临床项目推进、商业活动拓展、营运资本补充以及其他一般公司用途。
Dianthus Therapeutics Inc. 宣布,公司拟将此次融资的净收益主要用于支持其临床项目推进、商业活动拓展、营运资本补充以及其他一般公司用途。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.